Recently, many leading figures in the field of cardiology gathered in Madrid to participate together.2025 European Society of Cardiology (ESC) Conference. At the conference, participants shared numerous innovative achievements, cutting-edge developments, and key data, providing a comprehensive showcase of the latest advancements in cardiac technology. Abbott, Edwards, Medtronic、Boston ScientificWell-known enterprises such as Medtronic and Abbott Diagnostics Medical Co., Ltd. made appearances, showcasing advanced technologies in areas like heart valves and pulsed field ablation. Below are the key highlights from this conference:

Abbott announced itsNavitor Transcatheter Aortic Valve Implantation (TAVI) System relies onVANTAGE Research results, successfully obtainedCE Landmark Expanded Indications. The research team inESC 2025 The results were displayed at the conference, and relevant research was published in "JACC: Cardiovascular Interventions.

Research data shows,Navitor Demonstrates excellence in terms of safety and efficacy. Upon completion12 Months Follow-up Prior to262 Among the patients, all-cause mortality or fatal/The disability stroke rate is only2.3%。30 At the right time, none of the patients had moderate or more severe paravalvular leakage (PVL), only13.6%The patients experienced mildPVL, with a lower incidence rate.Moreover, the technical success rate of the system is as high as97%`, and no surgical mortality cases.`12 At months, its hemodynamic performance is also excellent.

InESC 2025 During,ESC European Association for Cardio-Thoracic Surgery (EACTS) jointly released new guidelines for the management of valvular heart disease. The new guidelines address all severe aortic stenosis (AS) A simplified care pathway has been developed for patients, regardless of whether they are symptomatic or not. This shift represents a move towards proactive disease management, emphasizing the need to consider interventions for asymptomatic patients without being limited by cardiac function. Compared to the previous "watchful waiting" strategy, this is a significant advancement. At the same time, the new guidelines include transcatheter aortic valve replacement (TAVR) The age threshold was reduced to70 Years, demonstrated the commitment toTAVR Confidence in the safety, efficacy, and durability of the surgery.

Edward pointed out,Currently, itsSapien 3 Ultra Resilia The transcatheter aortic valve replacement system is the only approved treatment for asymptomatic severe cases in the United States and Europe.AS TheTAVR System.In addition, the new guidelines also strengthen the recommendations for transcatheter mitral and tricuspid valve repair and replacement therapies, and Abbott also stated that these guidelines apply to its products.MitraClip AndTriClip The system has a positive impact.

GE Healthcare InESC 2025 A series of cardiology innovation kits designed to improve workflow have been launched. The new technology, enhanced by artificial intelligence, aims to elevate clinical decision-making, increase workflow efficiency, and support cardiovascular disease (CVD) for early diagnosis and treatment. Among them,ViewPoint EchoPilot、CardIQ Suite、Revolution Vibe AndComboLab AltiX AI.i New products such as ... have attracted much attention.

At the same time, the company also released its latest and most advanced cardiovascular ultrasound system.Vivid Pioneer. The system in existingVivid Redesigned on the platform basis, providing clinical doctors with2D、4D With color flow imaging support, it can streamline workflows and enhance diagnostic confidence. Currently,Vivid Pioneer Has been obtainedCE Logo andFDA 510（k) Approval.

Active Monitoring of Atrial Fibrillation Led by the University of Oxford (AMALFI) Randomized clinical trial results inESC 2025 Published above. The study shows that home-basedZio Long-term continuous monitoring (LTCM) Screening can improve atrial fibrillation (AFib) Detection rate and shorten diagnosis time.

Zio LTCM Using a prescription-only, patch-based ECG monitor capable of continuously and uninterruptedly capturing data for up to14 Data of the day. It also appliesZEUS（Zio Electrocardiogram Software System andFDA ApprovedAI Algorithm, providing a wear-end report reviewed and verified by qualified cardiac technicians.

In2.5 During the year of follow-up,AMALFI The study evaluated the labels onZio XT Equipment. Compared with routine care, the monitoring time is up to14 The device can improveAFib Testing. The study was conducted entirely remotely and recruited5,040 Eligible participants were randomly assigned to either wear on the basis of routine careZio 14 Days, or only continue routine care.

Johnson & Johnson Medical Technology Co.Abiomed Department inESC 2025 Reported upwardsImpella CP Positive Outcomes of Routine Use of Cardiac Pump Systems.Impella CP It is the world's smallest heart pump, capable of entering the heart to temporarily take over the blood-pumping function, allowing the heart to rest and recover while maintaining the flow of oxygenated blood throughout the body.The research results show that the use ofImpella CP Can significantly reduce the absolute mortality rate.

In addition,SECURE Sub-study of the ResearchVARIPURE The results were also shared at the conference. The study evaluatedJ&J MedTech Varipulse In TreatmentAFib Pulsed Field Ablation (PFA) Application in the program. In the analysis of791 Among the patients,Varipulse Demonstrates strong safety, high acute efficacy, and surgical efficiency. The incidence of primary adverse events is only0.6%, no stroke report, acute pulmonary vein isolation (PVI) Success rate as high as99.7%`, and the researchers highly adhered to the recommended ablation workflow.`

Boston Scientific inESC 2025 Shared onFARADISE Global Registration1,100 One-Year Outcomes in Multiple Patients.Farapulse As a pulsed field ablation (PFA) System, forAFib Treatment Offers New Options. The system was2024 At the beginning of the year, receivedFDA Approved, and the approval scope was expanded this summer. The results showed,Farapulse Under different ablation strategies andAFib Both types (paroxysmal and persistent) have demonstrated good surgical and safety outcomes as well as clinical effectiveness.

ForWatchman FLX Left Atrial Appendage Occlusion (LAAC) Device,OPTION Results of the sub-analysis of the trial with2024 The data shared in the year is consistent.This device can effectively prevent non-valvularAFib The patient's left atrial appendage (LAA) Thromboembolism, reducing the risk of stroke while significantly decreasing bleeding in both high-risk and low-risk patients.

Medtronic stated,ItsOmniaSecure It is the smallest defibrillation lead in the world, with a diameter of only4.7 Fr(Approx.1.6 Millimeters, equivalent to the diameter of graphite in a wooden pencil). The defibrillator lead was4 Monthly AcquisitionFDA Approved for placement in the right ventricle.

InESC 2025 The research results published on show that globallyLEADR LBBAP The test evaluated small-diameter defibrillation leads. The study showed,OmniaSecure Achieved safety and efficacy goals within three months. When placed in the left bundle branch (LBB) When performing physiological pacing in the region, the device achieved100%The success rate of defibrillation and2.3%LowOmniaSecure Incidence of lead-related major complications. Currently, the device is still under research.LBB Pacing-related applications.

END

More exciting content

Welcome to follow WeChat Video Channel

Instrument Family

Related Reading

Tap for more!

Largest Health Insurer Sues Largest Imaging Group

Monopoly in China's Market: Ophthalmology Giant's Billion-Dollar Acquisition Faces Opposition

Huitai Medical, Major Personnel Changes

China's Neurosurgery "Hidden Champion" Enters a New Track

Report Released: Which is Stronger, the Two Photon-Counting CT Models Made in China?

China's Leading Imaging Company Launches New Base

China's First Centralized Procurement, No "Lowest Price Wins"

China's First! Self-Developed Photon-Counting CT Detector Successfully Mass-Produced

Industry Giant Shuts Down Medical Device Manufacturing Completely

How About the Level of China's First Photon-Counting CT Just Approved?

BusinessBusiness cooperation email: qxzj@landianyiliao.com